New Retina Radio
09.26.25
What happens when patients with neovascular age-related macular degeneration (nAMD) show suboptimal response to faricimab (Vabysmo, Genentech/Roche) and are switched to high-dose aflibercept (Eylea HD, Regeneron)? Ben Young, MD, moderates a discussion with Pheobe Mellen, MD, and Jordan Deaner, MD, exploring real-world outcomes from a retrospective study of 135 eyes. The group dives into the implications for clinical practice and tries to parse apparently conflicting data regarding anatomic changes. Drs. Mellen and Deaner reflect on their own approaches to treating recalcitrant cases and debate what this paper means for the future of anti-VEGF therapy.
View full description +
Editorially Independent Content Supported by Genentech and Astellas.
New Retina Radio is forging forward with education, and they’re partnering with Vit Buckle Society to make it happen. Listen to hear quick-hit reviews of journal articles delivered by VBS members—all from the comfort of your podcast feed.
Subscribe
02.05.26
What I Wish I Knew: Insights From the Next Generation of Retina SpecialistsNemo Patel, MD; Sam Minaker, MD; and Has Al-khersan, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
02.05.26
Practical Insights on Adopting FDA-Approved Treatments Into PracticeNemo Patel, MD; Danny Mammo, MD; and Matthew Donovan, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
02.05.26
The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA TreatmentNemo Patel, MD and Patrick Staropoli, MD
This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
01.15.26
New Retina Radio Journal Club w/ VBS: Diagnosis Delays in Stargardt DiseaseAlexis Warren, MD; Jesse Sengillo, MD; and Sruthi Arepalli, MD
Sponsored by Genentech
12.18.25
New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and GraduatesNikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD
Editorially Independent Content Supported by Genentech
12.09.25
DME, DR, and Next-Generation TherapiesDavid Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Regeneron.
12.09.25
Wet AMD and Next-Generation TherapiesDavid Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Regeneron.
Show More